Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 5 of 29
-
Patent-free, low-cost vaccines highly protective against severe COVID
A new analysis of 390,459 participants assessing 14 different COVID-19 vaccines has identified no significant difference in efficacy against both symptomatic and severe...
-
TNP+ opposes patent claims on Lenacapavir
TNP+, MMA’s partner in Thailand, has filled an opposition against Markush patent claims on lenacapavir, a new, long-acting antiretroviral drug,...
-
In times of peace and in times of war: 100% LIFE outstanding work in Ukraine
After two years of the worst pandemic in recent history, 2022 marked an extra tragic event in the history of...
-
GSIPA2M – Day 2
Welcome to Day 2 of GISPA2M 2022! Plenary III – Big Pharma’s multiverse of Madness Andrew Hill, University of Liverpool,...
-
GSIPA2M – Day 1
Welcome to the first day of 2022 GSIPA2M – The Pandemic Edition: Reclaiming Access Sergiy Kondratyuk, ITPC Global, Ukraine Sergiy...
-
GSIPA2M 2022 – The Pandemic Edition: Reclaiming Access
Civil Society from across the globe will gather in Istanbul from the 19th to the 21st of July 2022 for...
-
Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline
July 1, 2022 – A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global...
-
Médecins du Monde challenges patents on COVID-19 vaccine
Médecins du Monde (MdM), a global medical humanitarian organization, has exposed Pfizer/BioNTechs’s patent abuse on the COVID-19 vaccine by challenging...
-
Same Meds, New Patents: What Do Activists Need to Know About Long-Acting Formulations?
Long-Acting Formulations (LAFs) have the potential to make treatment for hepatitis C (HCV) and tuberculosis (TB) easier to adhere to,...
-
COVID-19 – entering year three of normalizing profit over life
March 2022 marked the beginning of the third year of the COVID-19 pandemic. The status quo hasn’t changed: as pharmaceutical...
-
COVID Advocates Advisory Board meeting with Johnson & Johnson (J&J)/Janssen
Directly posted from CAAB Vax: Last November 15, a group of advocates working on vaccine access issues met with representatives...
-
TNP+ demands that Thailand’s Minister of Health “unlock” Hepatitis C treatment
On 7 February 2022, during Thailand’s National Health Security Board meeting, a representative from the Thai Network of People Living...